Recent research indicates that Dectin-1, similar to other PRRs in tumor contexts, plays a dual role, acting both as a tumor suppressor and promoter, depending on tumor type and microenvironmental heterogeneity. This evidence concerns the gene CLEC7A and neoplasm.